Wednesday, October 31, 2018

Hypera Pharma invests R $286.3 mi in innovation in 3tri18

The Hypera Pharma invested R $286.3 million, or 5.1% of your billing, in innovation throughout the third quarter of this year, record amount. From July to September the 11 launched new pharmaceutical products. Year to date, were 34 releases. The approximately 30% Hypera points out that the company's net revenue already comes from medicines launched in the last five years.
O Estado de S. Paulo - 31/10/2018 News Item translated automatically
Click HERE to see original
Other news
DATAMARK LTDA. © Copyright 1998-2021 ®All rights reserved.Av. Brig. Faria Lima,1993 third floor 01452-001 São Paulo/SP